Overview

Poïesis Therapeutics Ltd is a biotechnology start-up focused on sourcing and in-licensing late stage therapeutics and diagnostics from human biotechnology research and developing them to address unmet needs in pets – dogs, cats and horses. We have successfully raised over £300,000 of our £400,000 seed round and are raising another £100,000 to close our round.

Video Pitch


Management Team

President and Chief Executive Officer

Jessica Dugan

Jessica is an equine veterinarian with 22 years of practice experience and has owned and managed a large practice since 1996. She holds a Doctor of Veterinary Medicine degree from the University of California at Davis and an MBA from London Business School.

Chief Business Officer and Co-Founder

Richard Keatinge

Richard has more than 25 years of biotechnology industry experience in the US and Europe. He has deep business development experience, recently as the Chief Business Officer at Cytheris SA (Paris) and prior to that as Managing Director and VP of BioAlliance Pharma (Paris). While at BioAlliance (now Onxeo), he led the company’s oversubscribed IPO on NYSE Euronext. He holds degrees from University of California at Berkeley and Harvard University.


Don't See your Startup?

Create a free profile on Tech.London

Create a profile

List your startup

Be discovered in London’s tech & startup community by creating a company profile.

Startup listings for Tech.London are powered by Gust, the world’s largest platform in startup funding. You can update your profile at any time via the Gust dashboard.

You’ll also have a free account on Gust.com, where you can share your profile with investors to get funding.

Get started×

Tech.London
Weekly

Get London tech news, jobs, and a preview of upcoming events straight to your inbox each week for free.

Keep me updated

Tech.London Weekly

×